Fenflor

1 x 100 ml

Liquid for injection, solution

Active substance

Florfenicol : 300 mg/ml

ATC code

QJ01BA90 Florfenicol

QJ01BA Amphenicols

QJ01B Amphenicols

QJ01 Antibacterials for systemic use

QJ Antiinfectives for systemic use

Species

Cattle.

Indications

Diseases caused by florfenicol susceptible bacteria.

Treatment and metaphylaxis of respiratory tract infections in cattle due to Mannheimia haemolytica, Pasteurella multocida and Histophilus somni, where the presence of the disease in the herd has been established.

Dose to be administered and administration route

Intramuscular and subcutaneous use.

For treatment:

Intramuscular use: 20 mg/kg bodyweight (1 ml/15 kg) to be administered twice 48 hours apart.

Subcutaneous use: 40 mg/kg bodyweight (2 ml/15 kg) to be administered once only using a 16 gauge needle.

For metaphylaxis where the presence of the disease in the herd has been established:

Subcutaneous use: 40 mg/kg bodyweight (2 ml/15 kg) to be administered once only using a 16 gauge needle.

The dose volume given at any one injection site should not exceed 10 ml.

The injection should only be given in the neck.

To ensure a correct dosage, body weight should be determined as accurately as possible.

Adverse reactions

Cattle:

Very rare

(<1 animal / 10,000 animals treated, including isolated reports):

Anaphylactic reaction

Undetermined frequency

(cannot be estimated from the available data)

Reduced food intake^[1]

Loose stool¹

Injection site swelling^[2]

Injection site inflammation^[3]

¹Quick and complete recovery upon termination of treatment.

²After intramuscular administration: may persist for 14 days; after subcutaneous administration: may persist for 41 days.

³After intramuscular administration: may persist for 32 days; after subcutaneous administration: may persist for 41 days.

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See also section 16 of the package leaflet for contact details.